Two Sigma Advisers’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,890,200
Closed -$3.96M 87
2025
Q4
$3.96M Buy
2,890,200
+108,600
+4% +$143K 0.01% 923
2025
Q3
$3.45M Buy
2,781,600
+1,014,200
+57% +$1.21M 0.01% 888
2025
Q2
$2M Sell
1,767,400
-433,400
-20% -$576K ﹤0.01% 1120
2025
Q1
$3.21M Sell
2,200,800
-501,400
-19% -$945K 0.01% 966
2024
Q4
$5.76M Buy
2,702,200
+291,800
+12% +$720K 0.01% 665
2024
Q3
$6.75M Buy
2,410,400
+167,900
+7% +$448K 0.02% 607
2024
Q2
$5.23M Buy
2,242,500
+911,400
+68% +$2.69M 0.01% 739
2024
Q1
$5.95M Buy
1,331,100
+53,400
+4% +$223K 0.01% 709
2023
Q4
$4.1M Buy
1,277,700
+300,500
+31% +$852K 0.01% 902
2023
Q3
$3.1M Sell
977,200
-237,500
-20% -$1.04M 0.01% 966
2023
Q2
$6.04M Sell
1,214,700
-80,100
-6% -$433K 0.02% 682
2023
Q1
$6.4M Buy
1,294,800
+334,400
+35% +$2.14M 0.02% 713
2022
Q4
$6.04M Buy
960,400
+737,900
+332% +$6.83M 0.02% 706
2022
Q3
$2.4M Buy
222,500
+90,000
+68% +$1.22M 0.01% 1076
2022
Q2
$1.51M Sell
132,500
-100,000
-43% -$888K ﹤0.01% 1370
2022
Q1
$2.12M Buy
+232,500
New +$2.42M 0.01% 1226
2021
Q3
Sell
-67,800
Closed -$1.77M 2426
2021
Q2
$1.77M Sell
67,800
-346,300
-84% -$9.88M ﹤0.01% 1350
2021
Q1
$14.6M Buy
414,100
+62,300
+18% +$2.1M 0.04% 438
2020
Q4
$8.88M Buy
351,800
+14,300
+4% +$466K 0.02% 607
2020
Q3
$12.7M Buy
337,500
+305,300
+948% +$11.5M 0.04% 461
2020
Q2
$1.38M Buy
+32,200
New +$1.16M ﹤0.01% 1415

Other funds holding ALLO